Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) was held by 1 institutional investor that filed 13F reports for the quarter ended June 30, 2026.
Total shares held in Aspire Biopharma Holdings fell 99.72% versus Q1 2026, while the number of holders fell 92.86% versus Q2 2025.
Aspire Biopharma Holdings' one institutional holder owned 33 shares in total at the end of Q2 2026, down 11.74K from the prior quarter and down 1.67K from a year earlier.
Valley Wealth Managers, Inc. was the top holder of Aspire Biopharma Holdings as of June 30, 2026, with 33 shares.